Sepehr Azari

Array ( [id] => 20288766 [patent_doc_number] => 20250314009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => ODOR CONTROL COMPOSITION CONCENTRATES [patent_app_type] => utility [patent_app_number] => 19/178329 [patent_app_country] => US [patent_app_date] => 2025-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5242 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19178329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20163838 [patent_doc_number] => 20250255884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS [patent_app_type] => utility [patent_app_number] => 19/172483 [patent_app_country] => US [patent_app_date] => 2025-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19172483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20163838 [patent_doc_number] => 20250255884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-14 [patent_title] => CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS [patent_app_type] => utility [patent_app_number] => 19/172483 [patent_app_country] => US [patent_app_date] => 2025-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8439 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 228 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19172483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20067067 [patent_doc_number] => 20250205289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-26 [patent_title] => MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN [patent_app_type] => utility [patent_app_number] => 19/075217 [patent_app_country] => US [patent_app_date] => 2025-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4551 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19075217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20341757 [patent_doc_number] => 12465472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-11 [patent_title] => Methods of insect control for an animal, products thereof and methods for their preparation [patent_app_type] => utility [patent_app_number] => 18/900544 [patent_app_country] => US [patent_app_date] => 2024-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 15 [patent_no_of_words] => 13720 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 156 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18900544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19808401 [patent_doc_number] => 12239760 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-03-04 [patent_title] => Antibacterial conductive self-healing hydrogel [patent_app_type] => utility [patent_app_number] => 18/898561 [patent_app_country] => US [patent_app_date] => 2024-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 60 [patent_no_of_words] => 13080 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18898561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19496476 [patent_doc_number] => 20240335494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => TOPICAL MUSCLE RELAXATION COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/745158 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19496476 [patent_doc_number] => 20240335494 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => TOPICAL MUSCLE RELAXATION COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 18/745158 [patent_app_country] => US [patent_app_date] => 2024-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22094 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19477553 [patent_doc_number] => 20240325595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => Alginate Based Particles as a Temporary Embolic Agent [patent_app_type] => utility [patent_app_number] => 18/738275 [patent_app_country] => US [patent_app_date] => 2024-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19691120 [patent_doc_number] => 20250009665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => GASTRO-RESISTANT CONTROLLED RELEASE ORAL DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 18/738782 [patent_app_country] => US [patent_app_date] => 2024-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34798 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19477553 [patent_doc_number] => 20240325595 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-03 [patent_title] => Alginate Based Particles as a Temporary Embolic Agent [patent_app_type] => utility [patent_app_number] => 18/738275 [patent_app_country] => US [patent_app_date] => 2024-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29819 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19691120 [patent_doc_number] => 20250009665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => GASTRO-RESISTANT CONTROLLED RELEASE ORAL DOSAGE FORMS [patent_app_type] => utility [patent_app_number] => 18/738782 [patent_app_country] => US [patent_app_date] => 2024-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34798 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18738782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462277 [patent_doc_number] => 20240315946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => Method of Treating Oxidative Stress in Skin and Compositions Therefor [patent_app_type] => utility [patent_app_number] => 18/732895 [patent_app_country] => US [patent_app_date] => 2024-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7559 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18732895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19446561 [patent_doc_number] => 20240306691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => Personalized Nutritional Supplements and Methods of Making [patent_app_type] => utility [patent_app_number] => 18/671721 [patent_app_country] => US [patent_app_date] => 2024-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15006 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 283 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18671721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19447171 [patent_doc_number] => 20240307301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => CHEWABLE PHARMACEUTICAL PRODUCT FOR DELIVERY OF COLESEVELAM HYDROCHLORIDE [patent_app_type] => utility [patent_app_number] => 18/668674 [patent_app_country] => US [patent_app_date] => 2024-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3300 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18668674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784132 [patent_doc_number] => 20250057811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => FORMULATIONS OF AG10 [patent_app_type] => utility [patent_app_number] => 18/650542 [patent_app_country] => US [patent_app_date] => 2024-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18650542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19784132 [patent_doc_number] => 20250057811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => FORMULATIONS OF AG10 [patent_app_type] => utility [patent_app_number] => 18/650542 [patent_app_country] => US [patent_app_date] => 2024-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6267 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18650542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359265 [patent_doc_number] => 20240261299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST [patent_app_type] => utility [patent_app_number] => 18/630275 [patent_app_country] => US [patent_app_date] => 2024-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18630275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359265 [patent_doc_number] => 20240261299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST [patent_app_type] => utility [patent_app_number] => 18/630275 [patent_app_country] => US [patent_app_date] => 2024-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18630275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359265 [patent_doc_number] => 20240261299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => SOLID DOSAGE FORMULATIONS OF AN OREXIN RECEPTOR ANTAGONIST [patent_app_type] => utility [patent_app_number] => 18/630275 [patent_app_country] => US [patent_app_date] => 2024-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18630275 [rel_patent_id] =>[rel_patent_doc_number] =>)